Skip to main content

Table 4 Subgroup analysis of aesthetic outcome among patients with and without NACT

From: Reconstructive outcome analysis of the impact of neoadjuvant chemotherapy on immediate breast reconstruction: a retrospective cross-sectional study

Outcome

All (n = 187)

Implant-based reconstruction (n = 86)

Autologous reconstruction (n = 101)

NACT (n = 35)

Non-NACT (n = 152)

p value

NACT (n = 15)

Non-NACT (n = 71)

p value

NACT (n = 20)

Non-NACT (n = 81)

p value

Breast shape of reconstructive site

3.6 ± 0.8

3.8 ± 0.7

0.136

3.1 ± 0.8

3.5 ± 0.8

0.092

4.0 ± 0.6

4.1 ± 0.5

0.429

Symmetry of infra-mammary fold

3.9 ± 0.7

4.0 ± 0.7

0.524

3.4 ± 0.7

3.7 ± 0.8

0.123

4.2 ± 0.5

4.1 ± 0.6

0.552

Symmetry of breast volume

3.7 ± 0.7

3.8 ± 0.7

0.575

3.4 ± 0.8

3.7 ± 0.8

0.218

4.0 ± 0.5

3.9 ± 0.6

0.628

Symmetry of breast shape

3.4 ± 0.8

3.7 ± 0.8

0.128

3.0 ± 0.8

3.5 ± 0.9

0.072

3.8 ± 0.6

3.8 ± 0.6

0.622

Overall outcomes

3.6 ± 0.8

3.8 ± 0.7

0.052

3.1 ± 0.8

3.6 ± 0.7

0.035*

3.9 ± 0.6

4.0 ± 0.5

0.332

  1. NACT neoadjuvant chemotherapy